Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3278-3285

  Henriquez, Soledad ^a   Calderon, Claudia ^b   Quezada, Marisol ^a   Oliva, Bárbara ^a   Bravo, Maria Loreto ^a   Aranda, Evelyn ^a   Kato, Sumie ^c   Cuello, Mauricio A ^c   Gutiérrez, Jorge ^b   Quest, Andrew F G ^b   Owen, Gareth I ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; PROGESTERONE RECEPTOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; IMMUNOFLUORESCENCE; LIPID MEMBRANE; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; UPREGULATION;

BLOOD COAGULATION; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; FACTOR VIIA; FACTOR X; FEMALE; HUMANS; LIPOPROTEINS; MEMBRANE MICRODOMAINS; NEOPLASM INVASIVENESS; PROGESTERONE; PROTEIN TRANSPORT; RECEPTORS, PROGESTERONE; RECOMBINANT PROTEINS; THROMBOPLASTIN; TIME FACTORS; UP-REGULATION;

EID: 80053168223     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22689     Document Type: Article

References (42)

1. Ahamed J, Versteeg HH, Kerver M, et al. 2006. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 103: 13932-13937.
2. Amirkhosravi A, Meyer T, Amaya M, et al. 2007. The role of tissue factor pathway inhibitor in tumor growth and metastasis. Semin Thromb Hemost 33: 643-652.
3. Bach R, Rifkin DB. 1990. Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87: 6995-6999.
4. Bach R, Konigsberg WH, Nemerson Y. 1988. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry 27: 4227-4231.
5. Banner DW, D'Arcy A, Chene C, et al. 1996. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380: 21-23.
6. Barrowcliffe TW, Fábregas P, Jardi M, Cancelas J, Rabaneda M, Felez J. 2002. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb Haemost 87: 442-449.
7. Baugh RJ, Broze GJ, Krishnaswarmy S. 1998. Regulation of extrinsic pathway Factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 273: 4378-4386.
8. Bender F, Montoya M, Monardes V, et al. 2002. Caveolae and caveolae-like membrane domains in cellular signaling and disease: Identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 35: 151-167.
9. Callander NS, Varki N, Rao LV. 1992. Immunohistochemical identification of tissue factor in solid tumors. Cancer 70: 1194-1201.
10. Chen VM, Hogg PJ. 2006. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 4: 2533-2541.
11. Dorfleutner A, Ruf W. 2003. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 102: 3998-4005.
12. Egorina EM, Sovershaev MA, Osterud B. 2008. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res 122: 831-837.
13. Felley-Bosco E, Bender FC, Courjault-Gautier F, et al. 2000. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc Natl Acad Sci USA 97: 14334-14339.
14. Hamik A, Setiadi H, Bu G, McEver RP, Morrissey JH. 1999. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J Biol Chem 274: 4962-4969.
15. Hembrough TA, Swartz GM, Papathanassiu A, et al. 2003. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 63: 2997-3000.
16. Henriksson CE, Klingenberg O, Hellum M, et al. 2007. Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death. Thromb Res 119: 621-630.
17. Iakhiaev A, Pendurthi UR, Voigt J, Ezban M, Vijaya Mohan, Rao L. 1999. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. J Biol Chem 274: 36995-37003.
18. Kasthuri RS, Taubman MB, Mackman N. 2009. Role of tissue factor in cancer. J Clin Oncol 27: 4834-4838.
19. Kato S, Pinto M, Carvajal A, et al. 2005. Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1. J Clin Endocrinol Metab 90: 1181-1188.
20. Konigsberg W, Kirchhofer D, Riederer MA, Nemerson Y. 2001. The TF:VIIa complex: Clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost 86: 757-771.
21. Krikun G, Hu Z, Osteen K, Bruner-Tran KL, et al. 2010. The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol 176: 1050-1056.
22. Le DT, Rapaport SI, Rao LV. 1992. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 267: 15447-15454.
23. Lupu C, Goodwin CA, Westmuckett AD, et al. 1997. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol 17: 2964-2974.
24. Mandal SK, Iakhiaev A, Pendurthi UR, Rao LV. 2005. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: Modulation of tissue factor activity by membrane cholesterol. Blood 105: 153-160.
25. Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL, Broze GJ Jr. 1997. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J 327: 577-583.
26. Mourdjeva M, Popova Z, Kyurkchiev D, et al. 2006. Progesterone-modulated phosphatidylserine externalization in apoptosis and activation of Jurkat cells. Am J Reprod Immunol 56: 249-257.
27. Mulder AB, Smit JW, Bom VJ, et al. 1996. Association of endothelial tissue factor and thrombomodulin with caveolae. Blood 88: 3667-3670.
28. Pendurthi UR, Rao LV. 2008. Role of tissue factor disulfides and lipid rafts in signaling. Thromb Res 122: 14-18.
29. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. 2007. Tissue factor activation: Is disulfide bond switching a regulatory mechanism? Blood 110: 3900-3908.
30. Popescu NI, Lupu C, Lupu F. 2010. Role of PDI in regulatinf TF: FVIIa activity. Thromb Res 125: 38-41.
31. Quezada M, Diaz J, Henriquez S, et al. 2010. 2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Horm Cancer 1: 117-126.
32. Sanders NL, Bajaj SP, Zivelin A. 1985. Inhibition of tissue factor. Factor VIIa activity in plasma requires factor X and an additional plasma component. Blood 66: 204-212.
33. Schatz F, Krikun G, Caze R, Rahman M, Lockwood CJ. 2003. Progestin-regulated expression of tissue factor in decidual cells: Implications in endometrial hemostasis, menstruation and angiogenesis. Steroids 68: 849-860.
34. Semeraro N, Colucci M. 1997. Tissue factor in health and disease. Thromb Haemost 78: 759-764.
35. Sevinsky JR, Rao LV, Ruf W. 1996. Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 133: 293-304.
36. Tesselaar ME, Romijn FP, Van Der Linden IK, et al. 2007. Microparticle-associated tissue factor activity: A link between cancer and thrombosis? J Thromb Haemost 5: 520-527.
37. Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. 2000. Tissue factor expression in breast cancer tissues: Its correlation with prognosis and plasma concentration. Br J Cancer 83: 164-170.
38. Versteeg HH, Peppelenbosch MP, Spek CA. 2001. The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signalling? Thromb Haemost 86: 1353-1359.
39. Vrana JA, Stang MT, Grande JP, Getz MJ. 1996. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 56: 5063-5070.
40. Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. 1999. Tissue factor de-encryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coag Fibrinol 10: 201-210.
41. Zacharias DA, Violin JD, Newton AC, Tsien RY. 2002. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296: 913-916.
42. Zhong R, Huang RB, Song SJ. 2003. Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion. Ai Zheng 22: 1038-1041.